Fig. 1From: Expression of Myomaker and Myomerger in myofibers causes muscle pathologyValidation of transgenic models to activate Myomaker and Myomerger expression in myofibers. A Schematic of the breeding strategy for inducible expression of Myomaker within myofibers. B Schematic of the breeding strategy for inducible expression of Myomerger within myofibers. C qPCR analysis of Myomaker mRNA levels from the TA, rectus femoris, and gastroc muscles after 3 days of dox treatment. D qPCR analysis for Myomerger mRNA levels from the TA, rectus femoris, and gastroc muscles after 3 days of induction. E Western blot for Myomaker expression in the soleus, EDL, TA, gastroc, and rectus femoris after 3 days of dox treatment. F Western blot for Myomerger expression in the soleus, EDL, TA, gastroc, and rectus femoris after 3 days of dox treatment. G Western blot for Myomaker expression in the gastroc muscle after 2 weeks of induction. H Western blot for Myomerger in the gastroc after 2 weeks of induction. Statistical analyses and presentation: data are presented as mean ± SEM. C and D Two-tailed Student’s t-test; *P < 0.05, **P < 0.01Back to article page